The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Drug: clozaril     Quarter: 2016Q3

Total Drug/Injury Combinations: 311     Number of Pages: 16

DRUGNAME PT EventCount
CLOZARIL Diastolic dysfunction 2 view events
CLOZARIL Disturbance in attention 2 view events
CLOZARIL Ejection fraction decreased 2 view events
CLOZARIL Electrocardiogram PR prolongation 2 view events
CLOZARIL Exercise tolerance decreased 2 view events
CLOZARIL Gamma-glutamyltransferase increased 2 view events
CLOZARIL Granulocytopenia 2 view events
CLOZARIL Haematology test abnormal 2 view events
CLOZARIL High density lipoprotein decreased 2 view events
CLOZARIL Hypotension 2 view events
CLOZARIL Intestinal obstruction 2 view events
CLOZARIL Ischaemic cardiomyopathy 2 view events
CLOZARIL Judgement impaired 2 view events
CLOZARIL Liver injury 2 view events
CLOZARIL Lung neoplasm malignant 2 view events
CLOZARIL Lymphoma 2 view events
CLOZARIL Mean cell volume decreased 2 view events
CLOZARIL Metabolic syndrome 2 view events
CLOZARIL Mitral valve incompetence 2 view events
CLOZARIL Monocyte count increased 2 view events

Total Drug/Injury Combinations: 311     Number of Pages: 16

NOTE: EventCount numbers on this page include duplicate entries from event reports. (e.g. One event has DrugX entered twice, which equals 2 on this page.) The "view events" page treats these duplicates as single entries. (e.g. The 2 entries of DrugX for a single event are counted as 1 instance.)